{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:21:42Z","timestamp":1775841702000,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Exploring effective combination antibacterial therapies has become a research focus. This study selected seven common antibiotics to perform a series of tests on different Gram-negative bacteria isolated from clinical samples of chronic obstructive pulmonary disease patients. More than 70% of the strains exhibited multidrug resistance but remained sensitive to polymyxin B. The checkerboard assay revealed a significant synergistic effect between polymyxin B and tetracycline against different resistant strains, with fractional inhibitory concentration index values consistently below 0.5. Further time-kill curve analysis demonstrated that the use of minimal inhibit concentration of polymyxin B or tetracycline alone had limited bactericidal effects, while their combination significantly reduced bacterial counts by 2\u20133 log colony-forming units within 12 h. Additionally, the survival rate of larvae treated with the polymyxin B and tetracycline combination was significantly higher than that of the mono-therapy and untreated groups. In brief, this study demonstrates that the combination of polymyxin B and tetracycline exhibits potent antibacterial activity against multidrug resistant Gram-negative bacteria both in vitro and in vivo.<\/jats:p>","DOI":"10.1093\/lambio\/ovae129","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T03:03:38Z","timestamp":1734231818000},"source":"Crossref","is-referenced-by-count":4,"title":["Combination therapy strategies against multidrug resistant bacteria <i>in vitro<\/i> and <i>in vivo<\/i>"],"prefix":"10.1093","volume":"77","author":[{"given":"Daliang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, The First People's Hospital Of Jiashan County , Jiaxing 314100 Zhejiang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The First People's Hospital Of Jiashan County , Jiaxing 314100 Zhejiang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The First People's Hospital Of Jiashan County , Jiaxing 314100 Zhejiang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanglin","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The First People's Hospital Of Jiashan County , Jiaxing 314100 Zhejiang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qunchao","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The First People's Hospital Of Jiashan County , Jiaxing 314100 Zhejiang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chendong","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The First People's Hospital Of Jiashan County , Jiaxing 314100 Zhejiang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongdong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The First People's Hospital Of Jiashan County , Jiaxing 314100 Zhejiang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,14]]},"reference":[{"key":"2025010217204959900_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11111630","article-title":"Efficacy and safety of Colistin versus Tigecycline for multi-drug-resistant and extensively drug-resistant gram-negative pathogens-a meta-analysis","author":"Abushanab","year":"2022"},{"key":"2025010217204959900_bib2","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1128\/AAC.01231-08","article-title":"\u03b2-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli","volume":"53","author":"Al-Hasan","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010217204959900_bib3","first-page":"9101","article-title":"Nurse-led interventions in chronic obstructive pulmonary disease patients","volume":"19","author":"Aranburu-Imatz","year":"2022","journal-title":"Syst Rev Meta-Anal"},{"key":"2025010217204959900_bib4","first-page":"435","article-title":"In vitro and in vivo activity of theaflavin-epicatechin combinations versus multidrug-resistant Acinetobacter baumannii","author":"Betts","year":"2017"},{"key":"2025010217204959900_bib5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ijantimicag.2017.01.007","article-title":"Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model","volume":"49","author":"Cai","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"2025010217204959900_bib6","article-title":"Performance standards for antimicrobial susceptibility testing","volume-title":"CLSI","author":"Clinical and Institute, L.S","year":"2017"},{"key":"2025010217204959900_bib7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14787210.2020.1705155","article-title":"Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction","volume":"18","author":"Coates","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025010217204959900_bib8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/s12879-024-09515-6","article-title":"Spectrum and antimicrobial resistance in acute exacerbation of chronic obstructive pulmonary disease with pneumonia: a cross-sectional prospective study from Vietnam","volume":"24","author":"Dao","year":"2024","journal-title":"BMC Infect Dis"},{"key":"2025010217204959900_bib9","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3390\/antibiotics11081090","article-title":"In vitro assessment of the combination of antibiotics against some integron-harbouring Enterobacteriaceae from environmental sources","volume":"11","author":"Fadare","year":"2022","journal-title":"Antibiotics"},{"key":"2025010217204959900_bib10","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3389\/fmicb.2019.01791","article-title":"Typical and Atypical enteroaggregative Escherichia coli are both virulent in the Galleria mellonella model","volume":"10","author":"Guerrieri","year":"2019","journal-title":"Front Microbiol"},{"key":"2025010217204959900_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/ijmr.IJMR_755_18","article-title":"Next-generation strategy for treating drug resistant bacteria: antibiotic hybrids","volume":"149","author":"Gupta","year":"2019","journal-title":"Indian J Med Res"},{"key":"2025010217204959900_bib12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.coph.2018.05.004","article-title":"Mast cell activators as novel immune regulators","volume":"41","author":"Johnson-Weaver","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"2025010217204959900_bib13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/978-981-13-9871-1_19","article-title":"Combination of drugs: an effective approach for enhancing the efficacy of antibiotics to combat drug resistance","author":"Khan","year":"2019","journal-title":"Antibacterial Drug Discovery to Combat MDR: Natural Compounds, Nanotechnology and Novel Synthetic Sources"},{"key":"2025010217204959900_bib14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5334\/aogh.2423","article-title":"Cost of severe chronic obstructive pulmonary disease exacerbations in a high burden region in North India","volume":"85","author":"Koul","year":"2019","journal-title":"Anna Glob Health"},{"key":"2025010217204959900_bib15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40258-018-0431-5","article-title":"Economic burden of chronic obstructive pulmonary disease in Greece","volume":"17","author":"Kourlaba","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"key":"2025010217204959900_bib16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2174\/138945011794751519","article-title":"Mechanisms of bacterial resistance to antibiotics in infections of COPD patients","volume":"12","author":"Kyd","year":"2011","journal-title":"CDT"},{"key":"2025010217204959900_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jgar.2020.08.021","article-title":"Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a systematic review and network meta-analysis","volume":"24","author":"Liu","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"2025010217204959900_bib18","first-page":"1902227","article-title":"Metformin restores tetracyclines susceptibility against multidrug resistant bacteria","author":"Liu","year":"2020"},{"key":"2025010217204959900_bib19","first-page":"532","article-title":"Chronic obstructive pulmonary disease exacerbation fundamentals","volume":"26","author":"MacLeod","year":"2021","journal-title":"Diagn Treat Prevent Dis Impact"},{"key":"2025010217204959900_bib20","first-page":"2023","article-title":"Combating antimicrobial resistance by employing antimicrobial peptides: immunomodulators and therapeutic agents against","volume":"7","author":"Mehraj","year":"2024","journal-title":"Infect Dis"},{"key":"2025010217204959900_bib21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0954-6111(99)90004-5","article-title":"Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitaci\u00f3n Obstructiva al Flujo aEreo","volume":"93","author":"Miravitlles","year":"1999","journal-title":"Respir Med"},{"key":"2025010217204959900_bib22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s15010-019-01350-1","article-title":"Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"48","author":"Moghoofei","year":"2020","journal-title":"Infection"},{"key":"2025010217204959900_bib23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/2049-6958-6-5-299","article-title":"Epidemiology and costs of hospital care for COPD in Puglia","volume":"6","author":"Moretti","year":"2011","journal-title":"Multidiscip Respir Med"},{"key":"2025010217204959900_bib24","first-page":"6292","article-title":"Dual-mechanism glycolipidpeptide with high antimicrobial activity","volume":"17","author":"Niu","year":"2023","journal-title":"Immunomodulat Activity Potential Appl Combined Antibacterial Ther"},{"key":"2025010217204959900_bib25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"2025010217204959900_bib26","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/clinids\/14.5.1100","article-title":"Enhancement of the effectiveness of antimicrobial therapy by muramyl peptide immunomodulators","volume":"14","author":"O'Reilly","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2025010217204959900_bib27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1476-0711-8-18","article-title":"in vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii","volume":"8","author":"Principe","year":"2009","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2025010217204959900_bib28","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1128\/AAC.06268-11","article-title":"Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens","volume":"56","author":"Qureshi","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010217204959900_bib29","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/S0140-6736(17)31222-9","article-title":"Chronic obstructive pulmonary disease","volume":"389","author":"Rabe","year":"2017","journal-title":"Lancet North Am Ed"},{"key":"2025010217204959900_bib30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccm.2020.06.007","article-title":"Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations","volume":"41","author":"Ritchie","year":"2020","journal-title":"Clinics in Chest Medicine"},{"key":"2025010217204959900_bib31","first-page":"1288","article-title":"the respiratory threat posed by multidrug resistant gram-negative bacteria","author":"Rodrigo-Troyano","year":"2017"},{"key":"2025010217204959900_bib32","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1099\/jmm.0.000147","article-title":"in vitro activity of minocycline alone or in combination in multidrug-resistant Acinetobacter baumannii isolates","volume":"64","author":"Rodr\u00edguez","year":"2015","journal-title":"J Med Microbiol"},{"key":"2025010217204959900_bib33","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s10096-017-2930-y","article-title":"Serious fungal infections in Portugal","volume":"36","author":"Sabino","year":"2017","journal-title":"Europ J Clin Microbiol Infect Dis Offic Public Europ Soc Clin Microbiol"},{"key":"2025010217204959900_bib34","first-page":"15290","article-title":"Monotherapy versus combination therapy for multidrug-resistant gram-negative infections: systematic review and Meta-analysis","author":"Schmid","year":"2019"},{"key":"2025010217204959900_bib35","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0272-5231(05)70179-9","article-title":"The chronic obstructive pulmonary disease exacerbation","volume":"21","author":"Sherk","year":"2000","journal-title":"Clin Chest Med"},{"key":"2025010217204959900_bib36","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0034-2023","article-title":"The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus","author":"Simon","year":"2023"},{"key":"2025010217204959900_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/B978-0-12-820576-1.00012-6","article-title":"New approaches for targeting drug resistance through drug combination","volume-title":"Combination Therapy against Multidrug Resistance","author":"Singh","year":"2020"},{"key":"2025010217204959900_bib38","first-page":"1040","article-title":"a broad-spectrum antibiotic adjuvant reverses multidrug-resistant gram-negative pathogens","author":"Song","year":"2020"},{"key":"2025010217204959900_bib39","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.drudis.2016.05.015","article-title":"Drug combination therapy increases successful drug repositioning","volume":"21","author":"Sun","year":"2016","journal-title":"Drug Discovery Today"},{"key":"2025010217204959900_bib40","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"2025010217204959900_bib41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3109\/03009734.2014.899279","article-title":"Combination antibiotic therapy for multidrug-resistant gram-negative bacteria","volume":"119","author":"T\u00e4ngd\u00e9n","year":"2014","journal-title":"Ups J Med Sci"},{"key":"2025010217204959900_bib42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12866-024-03571-3","article-title":"Activity of polymyxin B combined with cefepime-avibactam against the biofilms of polymyxin B-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae in in vitro and in vivo models","volume":"24","author":"Tian","year":"2024","journal-title":"BMC Microbiol"},{"key":"2025010217204959900_bib43","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/fcp.12891","article-title":"Evaluation of combination therapies with colistin in an experimental mouse pneumonia model induced by carbapenem-resistant Acinetobacter\u2009baumannii strain","volume":"37","author":"Unal","year":"2023","journal-title":"Fundam Clin Pharmacol"},{"key":"2025010217204959900_bib44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejphar.2015.03.029","article-title":"Preclinical murine models of chronic obstructive pulmonary disease","volume":"759","author":"Vlahos","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"2025010217204959900_bib45","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3390\/ijms21031061","article-title":"Defeating antibiotic-resistant bacteria: exploring alternative therapies for a post-antibiotic era","volume":"21","author":"Wang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025010217204959900_bib46","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"Wedzicha","year":"2007","journal-title":"Lancet North Am Ed"},{"key":"2025010217204959900_bib47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","article-title":"Combination approaches to combat multidrug-resistant bacteria","volume":"31","author":"Worthington","year":"2013","journal-title":"Trends Biotechnol"},{"key":"2025010217204959900_bib48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12890-019-1000-x","article-title":"REALizing and improving management of stable COPD in China: a multi-center, prospective, observational study to realize the current situation of COPD patients in China (REAL)\u2014rationale, study design, and protocol","volume":"20","author":"Yang","year":"2020","journal-title":"BMC Pulm Med"},{"key":"2025010217204959900_bib49","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1128\/AAC.02994-15","article-title":"in vivo and in vitro efficacy of minocycline-based combination therapy for minocycline-resistant Acinetobacter baumannii","volume":"60","author":"Yang","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010217204959900_bib50","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1080\/1120009X.2021.2005755","article-title":"in vitro and in vivo comparison of eravacycline-and tigecycline-based combination therapies for tigecycline-resistant Acinetobacter baumannii","volume":"34","author":"Yin","year":"2022","journal-title":"J Chemother"}],"container-title":["Letters in Applied Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/lambio\/advance-article-pdf\/doi\/10.1093\/lambio\/ovae129\/61184980\/ovae129.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/lambio\/article-pdf\/77\/12\/ovae129\/61184980\/ovae129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/lambio\/article-pdf\/77\/12\/ovae129\/61184980\/ovae129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T17:21:05Z","timestamp":1735838465000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/lambio\/article\/doi\/10.1093\/lambio\/ovae129\/7924243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12,2]]}},"URL":"https:\/\/doi.org\/10.1093\/lambio\/ovae129","relation":{},"ISSN":["1472-765X"],"issn-type":[{"value":"1472-765X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,12]]},"article-number":"ovae129"}}